Document Detail

New pharmacologic therapies in chronic hepatitis B.
MedLine Citation:
PMID:  20951923     Owner:  NLM     Status:  In-Process    
Approximately 350 million persons worldwide are chronically infected with hepatitis B, which can result in cirrhosis, liver failure, and hepatocellular carcinoma. Currently, 2 interferons and 5 nucleos(t)ide analogues have been approved for the treatment of chronic hepatitis B (CHB). This article discusses the mechanisms of action, pharmacokinetics, optimal dose, clinical efficacy, and side effects of medications used for the treatment of CHB.
Chanunta Hongthanakorn; Anna S F Lok
Related Documents :
19712273 - Mitochondrial myopathy caused by clevudine therapy in chronic hepatitis b patients.
18331433 - Chronic hepatitis ameliorates anaemia in haemodialysis patients.
16260393 - Adjunctive therapies for hiv-1 associated neurologic disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Gastroenterology clinics of North America     Volume:  39     ISSN:  1558-1942     ISO Abbreviation:  Gastroenterol. Clin. North Am.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-10-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706257     Medline TA:  Gastroenterol Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  659-80     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Division of Gastroenterology, University of Michigan, 3110G Taubman Center, 1500 East Medical Center Drive, SPC 5362, Ann Arbor, MI 48109, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacokinetics and pharmacodynamics of peginterferon and ribavirin: implications for clinical effi...
Next Document:  Clinical pharmacology of portal hypertension.